Non-Polio Enterovirus inhibitors : scaffolds, targets, and potency - what's new ?

Archive ouverte

Roux, H.F.G. | Touret, Franck | Rathelot, P. | Sciò, P. | Coluccia, A. | Vanelle, P. | Roche, M.

Edité par CCSD -

Enterovirus (EV) is a genus that includes a large diversity of viruses spread around the world. They are the main cause of numerous diseases with seasonal clusters, like hand-foot-mouth disease (HFMD). A vaccine is marketed in China for the prevention of HFMD caused by EV-A71. Despite the need, no antiviral is marketed to date. Therefore, several compounds have been currently evaluated to inhibit non-polio Enterovirus (NPEV), namely direct antiviral agents and host target inhibitor. We propose to make a review of the latest molecules evaluated as NPEV inhibitors and to summarize structure-activity relationships between these inhibitors and their target. We provide access to all recent information on Enterovirus inhibitors, regardless of the species,to facilitate the design of future broad-spectrum drugs.

Consulter en ligne

Suggestions

Du même auteur

From the "One-Molecule, One-Target, One-Disease" concept towards Looking for multi-target therapeutics for treating Non-Polio Enterovirus (NPEV) Infections

Archive ouverte | Roux, H. | CCSD

Non-polio enteroviruses (NPEVs), namely coxsackieviruses (CV), echoviruses (E), enteroviruses (EV), and rhinoviruses (RV), are responsible for a wide variety of illnesses. Some infections can progress to life-threatening condition...

Looking for new broad spectrum enterovirus inhibitor

Archive ouverte | Roche, M. | CCSD

Virtual event

Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound

Archive ouverte | Kieffer, C. | CCSD

International audience. We present investigations about the mechanism of action of a previously reported 4-anilino-2-trichloromethylquinazoline antiplasmodial hit-compound (Hit A), which did not share a common mecha...

Chargement des enrichissements...